發(fā)布時(shí)間：2018-01-26 11:45

  本文關(guān)鍵詞： 早期宮頸腺癌 術(shù)后 預(yù)后分析　出處：《青島大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：背景:宮頸癌在世界范圍內(nèi)是除乳腺癌外導(dǎo)致女性發(fā)病和死亡最常見(jiàn)的惡性腫瘤,也是發(fā)病率最高的女性生殖系統(tǒng)惡性腫瘤。在發(fā)展中國(guó)家中,宮頸癌約占女性惡性腫瘤的24%,嚴(yán)重威脅婦女的健康、生命和生活質(zhì)量。宮頸癌常見(jiàn)的病理類型有宮頸鱗癌、宮頸腺癌和腺鱗癌三種類型,其中宮頸腺癌的發(fā)病率近年來(lái)逐漸升高,且更趨向于年輕化。宮頸腺癌與宮頸鱗癌相比表現(xiàn)出不同的生物學(xué)特性,如宮頸腺癌較宮頸鱗癌發(fā)病隱匿,臨床表現(xiàn)及婦科檢查各異,術(shù)前易誤診、漏診,易影響診斷和治療方法的選擇,且宮頸腺癌對(duì)放療不如宮頸鱗癌敏感,預(yù)后較差。雖然目前許多研究者正在致力研究與宮頸腺癌預(yù)后有關(guān)的因素,但宮頸腺癌確切的預(yù)后因素尚未明確。因此研究宮頸腺癌的預(yù)后相關(guān)因素,從而指導(dǎo)臨床治療是非常有意義的。研究目的:研究早期宮頸腺癌(I B1-II A期)經(jīng)手術(shù)治療后患者的預(yù)后相關(guān)因素。研究方法:對(duì)我院2005年1月1日至2015年1月1日初治的80例早期宮頸腺癌患者(FIGO分期IB1期-IIA期)進(jìn)行回顧性分析,該80例患者均行根治性子宮切除+雙附件切除+盆腔淋巴結(jié)清掃術(shù),收集所有患者的臨床資料,包括人口學(xué)資料、臨床資料及隨訪信息等,觀察和記錄患者的無(wú)瘤生存期(disease-free survival,DFS)與總生存期(overall survival,OS)。對(duì)年齡、腫瘤分期、分化程度、腫瘤直徑、絕經(jīng)、淋巴結(jié)轉(zhuǎn)移、間質(zhì)浸潤(rùn)深度、LVSI、腫瘤標(biāo)志物、累及附件、術(shù)前是否新輔助化療、術(shù)后是否行放化療、P16等因素進(jìn)行統(tǒng)計(jì)分析,采用Kaplan-Meier法計(jì)算生存率,Log-rank檢驗(yàn)進(jìn)行單因素分析及各組生存率曲線分布比較,Cox回歸模型進(jìn)行多因素分析,研究影響宮頸腺癌預(yù)后的因素。結(jié)果:回訪的80例早期宮頸腺癌患者發(fā)病最小年齡為29歲,最大發(fā)病年齡73歲,平均年齡為45.6歲,其中40-49歲的患者發(fā)病率最高,80例患者的生存時(shí)間為8-124個(gè)月,中位生存時(shí)間50個(gè)月,因?qū)m頸腺癌死亡者10例(12.5%)。所回訪患者的3年生存率為90.5%,5年生存率為87.1%。單因素分析顯示:年齡、絕經(jīng)、臨床分期、腫瘤直徑、分化程度、淋巴結(jié)轉(zhuǎn)移、間質(zhì)浸潤(rùn)深度的生存率差異有統(tǒng)計(jì)學(xué)意義(P0.05)。Cox風(fēng)險(xiǎn)比例回歸模型對(duì)年齡、臨床分期、絕經(jīng)與否、分化程度、腫瘤直徑、間質(zhì)浸潤(rùn)深度、淋巴結(jié)轉(zhuǎn)移等因素進(jìn)行多因素分析,結(jié)果顯示:間質(zhì)浸潤(rùn)深度、分化程度、絕經(jīng)是影響宮頸腺癌預(yù)后的獨(dú)立因素。結(jié)論:間質(zhì)浸潤(rùn)深度、分化程度、絕經(jīng)與否是影響早期宮頸腺癌術(shù)后預(yù)后的獨(dú)立因素。
[Abstract]:Background: cervical cancer is the most common malignant tumor in women except breast cancer, and it is also the most common malignant tumor in female reproductive system. Cervical cancer accounts for about 24% of female malignant tumors, which seriously threaten women's health, life and quality of life. The common pathological types of cervical cancer include cervical squamous cell carcinoma, cervical adenocarcinoma and adenosquamous carcinoma. The incidence of cervical adenocarcinoma gradually increased in recent years, and tend to be younger. Compared with cervical squamous cell carcinoma, cervical adenocarcinoma has different biological characteristics, such as cervical adenocarcinoma than cervical squamous cell carcinoma. The clinical manifestation and gynecological examination are different, preoperatively misdiagnosed, missed diagnosis, easy to affect the choice of diagnosis and treatment, and cervical adenocarcinoma is less sensitive to radiotherapy than cervical squamous cell carcinoma. Although many researchers are studying the factors related to the prognosis of cervical adenocarcinoma, the exact prognostic factors of cervical adenocarcinoma are not clear. Therefore, the prognostic factors of cervical adenocarcinoma are studied. Therefore, it is very meaningful to guide clinical treatment. Objective: to study the early stage I B 1-II A of cervical adenocarcinoma. Prognostic factors of patients undergoing surgical treatment. Methods: 80 cases of early cervical adenocarcinoma treated in our hospital from January 1st 2005 to January 1st 2015 were studied. FIGO stage: IB1 phase-IIA stage) were retrospectively analyzed. All the 80 patients underwent radical hysterectomy and double appendage resection of pelvic lymph node dissection. All the clinical data including demographic data clinical data and follow-up information were collected. The tumor-free survival time (DFSs) and total survival time (survival) of the patients were observed and recorded. For age, tumor staging, differentiation, tumor diameter, menopause, lymph node metastasis, interstitial infiltration depth of LVSIs, tumor markers, attachment, preoperative neoadjuvant chemotherapy. The survival rate was calculated by Kaplan-Meier method. Log-rank test was performed by univariate analysis and comparison of survival curve distribution among groups. Multivariate analysis was performed by Cox regression model. Results: the minimum age of 80 patients with early cervical adenocarcinoma was 29 years old and the maximum age was 73 years with an average age of 45.6 years. The survival time of 80 patients aged 40-49 years was 8-124 months, and the median survival time was 50 months. The 3-year survival rate was 90.5 and the 5-year survival rate was 87.1. Univariate analysis showed: age, menopause, clinical stage. The survival rates of tumor diameter, differentiation degree, lymph node metastasis, and depth of interstitial infiltration were significantly different from those of age, clinical stage, menopause or not. The degree of differentiation, the diameter of tumor, the depth of interstitial infiltration, lymph node metastasis and other factors were analyzed. The results showed that the depth of interstitial infiltration, the degree of differentiation. Conclusion: the depth of interstitial infiltration, the degree of differentiation and the menopause are independent factors influencing the prognosis of early cervical adenocarcinoma.
【學(xué)位授予單位】：青島大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R737.33

【參考文獻(xiàn)】

相關(guān)期刊論文 前8條

1 史博;袁彩萍;;宮頸癌病理分期與臨床分期差異性及影響淋巴結(jié)轉(zhuǎn)移的危險(xiǎn)因素[J];臨床醫(yī)學(xué)研究與實(shí)踐;2017年03期

2 潘在軒;陳敏;;HPV18型與早期子宮頸腺癌患者預(yù)后的相關(guān)性[J];海南醫(yī)學(xué);2016年17期

3 王曼;王淑珍;;探討淋巴脈管間隙浸潤(rùn)對(duì)早期宮頸癌預(yù)后的影響[J];首都醫(yī)科大學(xué)學(xué)報(bào);2015年02期

4 韓志紅;張秀珍;田小飛;楊雪梅;韓星梅;;早期宮頸腺癌術(shù)后的預(yù)后分析[J];現(xiàn)代腫瘤醫(yī)學(xué);2015年10期

5 吳素林;;早期宮頸腺癌患者的預(yù)后狀況及其影響因素研究[J];實(shí)用癌癥雜志;2014年07期

6 張蓉;李林;雷呈志;吳令英;白萍;李淑敏;;淋巴脈管間隙浸潤(rùn)對(duì)早期宮頸癌預(yù)后的影響[J];中華臨床醫(yī)師雜志(電子版);2013年16期

7 ;Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement[J];癌癥;2011年09期

8 周新華;宋磊;郭一帆;付曉宇;;宮頸腺癌86例臨床分析[J];中國(guó)婦產(chǎn)科臨床雜志;2010年05期

相關(guān)博士學(xué)位論文 前1條

1 楊濱;卡培他濱與放射線照射聯(lián)合治療子宮頸腺癌的效果與機(jī)制探討[D];中國(guó)醫(yī)科大學(xué);2007年

相關(guān)碩士學(xué)位論文 前1條

1 孟召靜;宮頸腺癌臨床特點(diǎn)及預(yù)后相關(guān)因素分析[D];福建醫(yī)科大學(xué);2012年

，

本文編號(hào)：1465520